Forvis Mazars Wealth Advisors’s T. Rowe Price US Equity Research ETF TSPA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$110M Buy
2,700,185
+403,204
+18% +$17.2M 2.1% 10
2025
Q4
$98.3M Buy
2,296,981
+437,719
+24% +$18.6M 1.86% 10
2025
Q3
$77.9M Buy
1,859,262
+382,500
+26% +$15.4M 1.55% 10
2025
Q2
$57.4M Buy
1,476,762
+527,957
+56% +$19M 1.24% 13
2025
Q1
$33.4M Buy
948,805
+557,959
+143% +$20.7M 0.8% 23
2024
Q4
$14.4M Buy
390,846
+98,875
+34% +$3.67M 0.33% 47
2024
Q3
$10.5M Buy
291,971
+122,596
+72% +$4.26M 0.24% 53
2024
Q2
$5.82M Buy
169,375
+100,150
+145% +$3.29M 0.15% 80
2024
Q1
$2.27M Buy
+69,225
New +$2.15M 0.06% 152

Other funds holding TSPA

Forvis Mazars Wealth Advisors's TSPA Position: Q1 2026 in Review

Forvis Mazars Wealth Advisors increased its T. Rowe Price US Equity Research ETF (TSPA) stake by 18% in Q1 2026, buying an estimated $17.2M and bringing the position to 2,700,185 shares worth $110M. The position accounts for 2.1% of the portfolio, ranked #10.

Forvis Mazars Wealth Advisors first reported a position in TSPA in Q1 2024 and has held it in 9 quarters since. 119 funds tracked by Wall St. Rank hold TSPA as of Q1 2026.

  • Forvis Mazars Wealth Advisors held 2,700,185 shares of T. Rowe Price US Equity Research ETF worth $110M as of Q1 2026.
  • Forvis Mazars Wealth Advisors bought 403,204 T. Rowe Price US Equity Research ETF shares in Q1 2026, an estimated $17.2M.
  • T. Rowe Price US Equity Research ETF made up 2.1% of Forvis Mazars Wealth Advisors's portfolio in Q1 2026, its #10 holding.
  • Forvis Mazars Wealth Advisors first reported a position in T. Rowe Price US Equity Research ETF in Q1 2024 and has held it in 9 quarters since.
  • 119 funds tracked by Wall St. Rank held T. Rowe Price US Equity Research ETF as of Q1 2026.

Based on Forvis Mazars Wealth Advisors's 13F filing for Q1 2026, filed 1 May 2026.